Patients with Type 2 diabetes who take the prescription medication Invokana (canagliflozin) either experience “significantly improved renal outcomes” or risk severe kidney damage – depending on which study you believe. In a press release issued last week, drug maker...

Despite the demonstrated links between lower limb amputations, kidney failure, osteoporosis and acute pancreatitis, Johnson & Johnson has followed through with its earlier plans to expand the market for its controversial diabetic medication, Invokana. This month, the...

While injury lawsuits over the diabetic medication Invokana (canagliflozin) continue to pile up against Johnson & Johnson subsidiary Janssen Pharmaceuticals, the manufacturer has entered into a distribution agreement with U.K.-based Mundipharma, giving the British...

Last year, the European Medicines Agency (EMA) started an investigation into the possibility that use of the diabetic medication Invokana (canagliflozin) increased a patient's risk of limb amputation. Although solid evidence of this risk had not yet been found, the...

If you were fully informed about the potential side effects of a medication, would you still choose to take it? This is the cause of action in the growing number of lawsuits against drug companies, such as those naming Janssen Pharmaceuticals and Mitsubishi Tanabe,...

Via America's Lawyer: According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease aren't even aware that they have it. Even worse, as many as 86-million Americans...

Last year (May 2016), the U.S. Food and Drug Administration issued an “advisory” to physicians regarding results of a continuing clinical trial indicating that use of the diabetes medication Invokana (canagliflozin) “may” increase the risk of lower limb amputations....

The diabetes “wonder drug,” Invokana (canagliflozin), has been demonstrated to cause a dangerous rise in blood acid levels (known as ketoacidosis) as well as serious loss of bone density (osteoporosis) – both of which manufacturer Janssen Pharmaceuticals and its...

In addition to ketoacidosis (dangerous acidity levels in the blood), kidney damage and a host of other harmful and even fatal side effects, the diabetic drug Invokana (canagliflozin) is now being implicated in acute pancreatitis, a serious – and sometimes fatal –...

One of the selling points of the prescription diabetes medication Invokana (canagliflozin) has been its role in helping patients shed excess pounds. However, a new study from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD) has found that...